iiinova — where your digital self keeps evolving

PANCAID @pancaid.bsky.social · 15/09/2026

We are proud to share that Prof. Klaus Pantel just had the opportunity at the 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐒𝐨𝐜𝐢𝐞𝐭𝐲 𝐨𝐟 𝐏𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐲 (𝐄𝐒𝐏) Congress in Stockholm to present the latest developments in liquid biopsy and its path towards clinical implementation. PANCAID is proud to be represented at such a leading forum.

000

PANCAID @pancaid.bsky.social · 04/09/2026

📢 Meet Prof. Klaus Pantel from PANCAID at the 38th ECP Congress in Stockholm, Sweden Molecular Diagnostics Pathology Symposium Room: K2 Date: Monday, September 14th 2026 Time: 16:45–17:40 Session: MD-04 – Future directions in MRD and liquid biopsy for solid tumours

010

PANCAID @pancaid.bsky.social · 03/08/2026

Clinical research is essential for improving patient care. In this week's glossary carousel we explain: • Clinical study • Clinical trial • Prospective studies • Retrospective studies These research designs help generate evidence that advances medicine. #ClinicalResearch #MedicalScience

010

PANCAID @pancaid.bsky.social · 27/07/2026

What adjustment methods can be applied to data? This week's glossary carousel explores: • Data fusion • Data harmonization • Data imputation #DataScience #AI #DataAdjustment #Model

010

PANCAID @pancaid.bsky.social · 20/07/2026

How do scientists know whether an AI model truly works? This week's glossary carousel explores: • Calibration • Discrimination • Overfitting These concepts help evaluate model reliability and performance. #DataScience #AI #ModelValidation

010

PANCAID @pancaid.bsky.social · 13/07/2026

📢 Save the date! ➡️ 15th International Congress on Liquid Biopsy 2027 ( #ISMRC2027 ) When 📆: 12 - 14 May 2027 Where 📍: Palma de Mallorca, Spain More info ℹ️: tacticsmd.net/congreso/ism... #SaveTheDate #Conference #LiquidBiopsy

021

PANCAID @pancaid.bsky.social · 13/07/2026

Building reliable AI models requires careful data preparation. In this week's glossary carousel we explain: • Training periods • Feature selection • Dimensionality reduction These steps help improve model performance and interpretability. #AIResearch #DataScience

040

PANCAID @pancaid.bsky.social · 06/07/2026

Machine learning models can uncover patterns hidden in large biomedical datasets. This week's glossary carousel explains: • Supervised learning • Unsupervised learning • Multimodal #machinelearning These techniques enable new discoveries in cancer detection and research. #AIinHealthcare

030

PANCAID @pancaid.bsky.social · 03/07/2026

🏆 Congratulations to PANCAID co-coordinator Prof. Matthias Löhr on receiving the Lifetime Achievement Award at the joint EPC/IAP Meeting! The award recognises his outstanding contributions to pancreatic disease research and leadership. @maloehr.bsky.social @ki.se #CancerResearch #PancreaticCancer

140

PANCAID @pancaid.bsky.social · 29/06/2026

Artificial intelligence is transforming medical research. In this week's glossary carousel we explain: • Artificial Intelligence • Machine Learning • Deep Learning These tools help scientists analyze complex biomedical data. #AI #HealthData #CancerResearch

021

Reposted by PANCAID

Pancreatic Cancer Europe @pce-europe.bsky.social · 24/06/2026

📍 PCE is at the 58th EPC/IAP Joint Meeting in Istanbul! Our Chairperson and Secretariat are representing the pancreatic cancer patient community, engaging with experts and partners to strengthen collaboration and advance better outcomes for patients.

011

Reposted by PANCAID

Pancreatic Cancer Europe @pce-europe.bsky.social · 23/06/2026

Proud to support the PANCAID project in making pancreatic cancer research more accessible and patient-centred. From glossary posts explaining key scientific terms to stakeholder videos sharing lived experiences and expert insights, these campaigns help bridge research and reality.

111

PANCAID @pancaid.bsky.social · 22/06/2026

Different biological layers reveal different aspects of disease. This week's glossary carousel explores: • Proteomics • Metabolomics • Multi‑omics integration Combining these approaches provides a more complete picture of cancer biology. #Omics #MultiOmics #CancerResearch

010

PANCAID @pancaid.bsky.social · 15/06/2026

Modern cancer research studies thousands of biological molecules simultaneously. This week's glossary carousel explains: • Omics • Genomics • Transcriptomics These technologies help scientists understand cancer at a systems level. #Omics #Genomics #CancerResearch

020

PANCAID @pancaid.bsky.social · 11/06/2026

This week, the PANCAID Steering Committee met virtually to review progress, discuss activities, and align on priorities. The next months will be both busy and exciting as we work together to maximise the project's scientific, clinical, and societal impact. #PancreaticCancer #LiquidBiopsy

021

PANCAID @pancaid.bsky.social · 08/06/2026

Small molecules and RNA fragments can provide powerful clues about disease. This week's glossary carousel explains: • MicroRNAs • Metabolites • Microbiome metabolites These biomarkers can help researchers detect and monitor cancer. #Biomarkers #CancerResearch

020

PANCAID @pancaid.bsky.social · 01/06/2026

Tumours release biological signals into the bloodstream. In this week’s glossary carousel we explain: • Circulating tumour cells • Extracellular vesicles • Exosomes Researchers study these signals to develop new diagnostic tools. #CancerBiology #LiquidBiopsy

030

PANCAID @pancaid.bsky.social · 28/05/2026

Yesterday, PANCAID members participated in the Hamburg Pankreasforum 2026, hosted at Universitätsklinikum Hamburg Eppendorf, bringing together top expertise in pancreatic health. 🩺🔬 #Pankreasforum #PancreaticCancer #Pancreas

010

PANCAID @pancaid.bsky.social · 25/05/2026

What if cancer could be detected through a simple blood test? This week's glossary carousel explores: • Liquid biopsy • Cell‑free DNA • Circulating tumour DNA These technologies could revolutionize early cancer detection. #LiquidBiopsy #CancerInnovation

021

PANCAID @pancaid.bsky.social · 18/05/2026

Biomarkers come in many forms: from molecules in blood to measurable clinical indicators. This week's glossary carousel explains: • CEA • Non‑omics #biomarkers • Outcomes in cancer research These indicators help clinicians evaluate disease progression and treatment success. #ClinicalResearch

000

PANCAID @pancaid.bsky.social · 11/05/2026

Biomarkers are measurable signals in the body that can indicate disease. In this week’s glossary carousel we explain: • Biomarkers • Biomarker panels • CA 19‑9 Researchers study biomarkers to improve cancer detection and monitoring. #Biomarkers #CancerDiagnostics

011

PANCAID @pancaid.bsky.social · 05/05/2026

🔔 🆕 Lab-SOP for prospective blood collection Harmonised workflows are crucial for coordinated #samplecollection and initial processing What's included: Plasma separation, Whole blood handling, Dried blood spots, Pre‑analytical steps, Transport conditions 🔓 doi.org/10.17044/sci... #LiquidBiopsy

020

PANCAID @pancaid.bsky.social · 04/05/2026

How reliable is a diagnostic tool in real-world settings? This week's carousel focuses on that: • Positive predictive value (PPV) • Negative predictive value (NPV) #Diagnostics #MedicalStatistics #CancerResearch

020

PANCAID @pancaid.bsky.social · 27/04/2026

Medical tests can produce several types of results. In this week's glossary carousel we explain: • True positives • True negatives • False positives Understanding these outcomes helps interpret diagnostic results and improve testing strategies. #MedicalTesting #Diagnostics #CancerResearch

020

PANCAID @pancaid.bsky.social · 24/04/2026

New Newsletter from the Prevention and Early Detection (Screening) Cluster out now! Packed with project updates from PANCAID, DIOPTRA, SANGUINE, LUCIA, @oncoscreen-project.bsky.social, and MammoScreen. Download and read the newsletter here: pancaid-project.eu/wp-content/u...

052

Reposted by PANCAID

transpan.bsky.social @transpan.bsky.social · 22/04/2026

📢 Liquid biopsy for pancreatic cancer: findings & challenges in the overseas scenario🧬 📅 April 23, 2026 ⏰ 14:00–15:00 (CET) 💻 More here: transpan.eu/transpan-web... Join us to explore new insights in pancreatic cancer research and the global challenges of liquid biopsy 🌍🔬 #LiquidBiopsy

transpan.eu

TRANSPAN Webinar: Liquid biopsy for pancreatic cancer: findings and challenges in the overseas scenario | Transpan

033

Reposted by PANCAID

transpan.bsky.social @transpan.bsky.social · 21/04/2026

Ever wondered what non-coding RNAs do in pancreatic ductal adenocarcinoma (PDAC)? 🧬🔬 In this review, we summarize a fast-moving field 🚀 with real translational potential 💡 in PDAC research—and what it could mean for future therapies 💊 Read here 📑: www.sciencedirect.com/science/arti...

sciencedirect.com

Non-coding RNAs as biomarkers and therapeutic targets in pancreatic cancer: Clinical implications and translational perspectives

Pancreatic cancer remains one of the most lethal malignancies, largely due to late diagnosis, marked tumor heterogeneity, and profound resistance to t…

052

PANCAID @pancaid.bsky.social · 20/04/2026

How do scientists evaluate whether a diagnostic test actually works? This week's glossary carousel explains: • Sensitivity • Specificity • Accuracy These measures help determine how effectively a test detects disease while avoiding incorrect results. #Diagnostics #MedicalResearch #CancerScreening

020

PANCAID @pancaid.bsky.social · 16/04/2026

🎙️Prof. Ellen Heitzer from the Medical Uni Graz was recently featured in a podcast! • Challenges of early #pancreaticcancer detection • Liquid Biopsy • Her research on ctDNA and MRD • The role of PANCAID 🎧 Listen here (German only): www.springermedizin.at/meduni-graz/... #liquidbiopsy

springermedizin.at

Client Challenge

000

Reposted by PANCAID

Matthias Löhr ʚїɞ @maloehr.bsky.social · 11/04/2026

This is the way to go! As we are doing w/ @pancaid.bsky.social

022

PANCAID @pancaid.bsky.social · 13/04/2026

Detecting cancer early can dramatically improve outcomes. This week's glossary carousel explains: • Diagnosis • Screening • Early detection These concepts are central to ongoing research aimed at improving survival rates for pancreatic cancer. #EarlyDetection #CancerAwareness #PancreaticCancer

021

PANCAID @pancaid.bsky.social · 06/04/2026

Cancer is not just a collection of tumour cells, it interacts with the body around it. This week’s glossary carousel explores: • Metastasis • The tumour microenvironment • Tumour vs host cells #CancerResearch #TumourBiology #PancreaticCancer

020

PANCAID @pancaid.bsky.social · 30/03/2026

Genetics and biological processes can strongly influence cancer development. This week we explain: • Hereditary #pancreaticcancer syndromes • KRAS mutations • Inflammation These concepts help researchers understand why certain cancers develop and how they progress. #CancerBiology #Genetics

021

PANCAID @pancaid.bsky.social · 25/03/2026

New masterclass now available 🎥 Klaus Pantel & Catherine Alix-Panabières provide an in-depth overview of liquid biopsy diagnostics: From early detection to clinical implementation. Watch here: youtu.be/uFuAvdRABTo #LiquidBiopsy #CancerResearch #PANCAID

011

Reposted by PANCAID

Pancreatic Cancer Europe @pce-europe.bsky.social · 23/03/2026

🟣 Did you know? There are different types of pancreatic cancer. The most common is pancreatic ductal adenocarcinoma, which begins in the cells that line the ducts of the pancreas. 👉 Learn more: pancreaticcancereurope.eu

031

PANCAID @pancaid.bsky.social · 23/03/2026

Who is more likely to develop #pancreaticcancer? Some individuals have a higher probability of developing the disease due to #genetic predisposition, lifestyle factors, or family history. This week’s explains: • Risk factors • Individuals at risk • Familial pancreatic cancer (FPC) #CancerRisk

010

PANCAID @pancaid.bsky.social · 16/03/2026

In this week's glossary carousel we explain: • Dysplasia • Lesion • Pancreatic intraepithelial neoplasia (PanIN) Understanding these early biological changes helps researchers identify opportunities for earlier detection and prevention. #PancreaticCancer #CancerResearch #EarlyDetection

011

Reposted by PANCAID

concentris research management gmbh @concentris.bsky.social · 04/02/2026

Cancer is unique; so must be our research approaches. On #WorldCancerDay, we highlight @fortee-eu.bsky.social , @pancaid.bsky.social & SATURN3: three research consortia tackling cancer from pediatric care to early detection and tumor heterogeneity. #UnitedByUnique #WCD2026

075

PANCAID @pancaid.bsky.social · 04/02/2026

🚨 500,000 #pancreaticcancer deaths in 2020. The biggest challenge: We can’t diagnose it in time. #WorldCancerDay reminds us that every diagnosis remains a race against time And we’re committed to develop a biomarker panel that can reliably detect PDAC at its earliest stages #UnitedByUnique #WCD2026

023

PANCAID @pancaid.bsky.social · 29/01/2026

What does “cell-free DNA” or “PanIN” mean? Our new PANCAID Glossary explains key #pancreaticcancer and research terms in clear, accessible language. 👉 pancaid-project.eu/for-patients... Thanks to all teams for input and to @pce-europe.bsky.social for checking the entries for accessibility!

043

PANCAID @pancaid.bsky.social · 18/12/2025

Thrilled to welcome Queen Mary University of London (@qmul.bsky.social) as an associated partner in PANCAID! QMUL contributes to WP3 and WP2, bringing expertise in biomarker analysis and data-driven methods. #HorizonEU #MissionCancer

031

PANCAID @pancaid.bsky.social · 15/12/2025

As the year comes to a close, let’s take a moment to reflect on our achievements of 2025. The year's highlights include: ✅ 2 scientific articles ✅ Stakeholder Dialogue Event, bringing together 55 participants from 21 countries and & organisations ✅ Meaningful collaborations with other EU projects

041

PANCAID @pancaid.bsky.social · 11/12/2025

We’re excited to welcome Eberhard Karls University Tübingen (@unituebingen.bsky.social) to the PANCAID consortium! Their expertise in WP2 strengthens our biomarker research and supports progress in early detection of #pancreaticcancer. #HorizonEU

041

PANCAID @pancaid.bsky.social · 04/12/2025

📺 Happening now! @scienceinnovation.ec.europa.eu is hosting "Advancing cancer care: personalised treatment and innovation" Prof. Klaus Pantel is panelist in the session "From Detection to Decision: Cutting-Edge Diagnostics in Precision Cancer Care." 👉 Watch here: www.youtube.com/live/z3qA1nQ...

youtube.com

Advancing cancer care: personalised treatment and innovation (part I)

YouTube video by EU Science & Innovation

021

PANCAID @pancaid.bsky.social · 02/12/2025

Excited that Prof. Klaus Pantel was speaker at the Inaugural EUnetCCC Educational Seminar in Barcelona yesterday, contributing "Liquid Biopsy: From Discovery to Clinical Implementation" #EUnetCCC #LiquidBiopsy #pancreaticcancer #precisiononcology #EUfunded

021

PANCAID @pancaid.bsky.social · 20/11/2025

Thank you to the European Cancer Organisation for showcasing our project at the #EuropeanCancerSummit 2025! Special thanks also to @pce-europe.bsky.social for participating at the event 💜 #pancreaticcancer #cancersummit

021

Reposted by PANCAID

cniostopcancer.bsky.social @cniostopcancer.bsky.social · 20/11/2025

- descubrimiento de una variante genética que aumenta el riesgo (Francisco X. Real) - avances hacia una biopsia líquida que permita la detección precoz con un análisis de sangre (Nuria Malats y @hps2022.bsky.social en @pancaid.bsky.social )

111

PANCAID @pancaid.bsky.social · 20/11/2025

Today is #WorldPancreaticCancerDay 💜 #Pancreaticcancer is projected to become the second leading cause of cancer-related deaths in Western societies by 2030. A stark reminder of why our work matters. Today, our thoughts are with all patients and families affected by this devastating disease. 💜 #WPCD

043

PANCAID @pancaid.bsky.social · 20/11/2025

Honored to host the 3rd Annual Cluster Meeting of the Prevention & Early Detection (Screening) Cluster in Brussels. We're joined by our cluster members MammoScreen, DIOPTRA, SANGUINE, LUCIA, and @oncoscreen-project.bsky.social. @horizoneu.bsky.social @ec.europa.eu #CancerPrevention #EarlyDetection

010

Reposted by PANCAID

Matthias Löhr ʚїɞ @maloehr.bsky.social · 19/11/2025

Such a pleasure to lead this consortium together with #klauspantel from #UKE! @ki.se is participating with several departments including #CLINTEC, #LIME, #NVS #yvonnewengström #niklaszethraeus

011